Bluejay Therapeutics

Bluejay Therapeutics makes progress in Hepatitis B and D Trials
Clinical Trials Arena
Fri, 06/2/23 - 10:20 am
Bluejay Therapeutics
clinical trials
BJT-778
hepatitis B
hepatitis D
Bluejay raises $41M to bring hepatitis B drugs to clinical testing
BioPharma Dive
Fri, 08/19/22 - 10:39 am
Bluejay Therapeutics
hepatitis B
funding